119 related articles for article (PubMed ID: 34388428)
1. Investigating the molecular structure of plasma in type 2 diabetes mellitus and diabetic nephropathy by synchrotron Fourier-transform infrared microspectroscopy.
Nimer R; Kamel G; Obeidat MA; Dahabiyeh LA
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Jan; 264():120259. PubMed ID: 34388428
[TBL] [Abstract][Full Text] [Related]
2. Plasma drop and thin-film revealed distinguished molecular structure in pre-eclampsia: An investigation using synchrotron Fourier-transform infrared microspectroscopy.
Dahabiyeh LA; Mansour RSH; Darwish W; Saleh SS; Kamel G
J Pharm Biomed Anal; 2022 Oct; 220():114981. PubMed ID: 35961213
[TBL] [Abstract][Full Text] [Related]
3. Investigating the molecular structure of placenta and plasma in pre-eclampsia by infrared microspectroscopy.
Dahabiyeh LA; Mansour RSH; Saleh SS; Kamel G
J Pharm Biomed Anal; 2020 May; 184():113186. PubMed ID: 32105942
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Serum Micro-RNA 152-3p in Type 2 Diabetes Mellitus with a Significant Elevation in Progressive Nephropathy.
Nasser M; Ibrahim KMF; Elnabawi WM; Ahmed TM
Egypt J Immunol; 2020 Jun; 27(2):81-92. PubMed ID: 33548980
[TBL] [Abstract][Full Text] [Related]
5. Review of early circulating biomolecules associated with diabetes nephropathy - Ideal candidates for early biomarker array test for DN.
Quan KY; Yap CG; Jahan NK; Pillai N
Diabetes Res Clin Pract; 2021 Dec; 182():109122. PubMed ID: 34742785
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in
Tsetsos F; Roumeliotis A; Tsekmekidou X; Alexouda S; Roumeliotis S; Theodoridis M; Thodis E; Panagoutsos S; Papanas N; Papazoglou D; Kotsa K; Yovos JG; Maltezos E; Passadakis P; Paschou P; Georgitsi M
Diab Vasc Dis Res; 2020; 17(6):1479164120970892. PubMed ID: 33164551
[TBL] [Abstract][Full Text] [Related]
7. Synchrotron-radiation sourced SR-IMS molecular spectroscopy to explore impact of silencing TT8 and HB12 genes in alfalfa leaves on the molecular structure and chemical mapping.
Lei Y; Hannoufa A; Christensen D; Yu P
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Dec; 243():118676. PubMed ID: 32810783
[TBL] [Abstract][Full Text] [Related]
8. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between cognitive impairment and diabetic nephropathy in patients with Type 2 diabetes mellitus].
Shi X; Zhang Y; Niu H; Wang R; Shen J; Zhou S; Yang H; Wang S; Wu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):143-50. PubMed ID: 26932211
[TBL] [Abstract][Full Text] [Related]
10. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
[TBL] [Abstract][Full Text] [Related]
11. Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy.
Liu L; Xiang K; Zheng T; Zhang R; Li M; Li J
Mol Cell Biochem; 2003 Dec; 254(1-2):353-8. PubMed ID: 14674716
[TBL] [Abstract][Full Text] [Related]
12. Early-onset of type 2 diabetes mellitus is a risk factor for diabetic nephropathy progression: a biopsy-based study.
Wu Y; Wang Y; Zhang J; Zhang R; Zhao L; Ren H; Zou Y; Wang T; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
Aging (Albany NY); 2021 Mar; 13(6):8146-8154. PubMed ID: 33686955
[TBL] [Abstract][Full Text] [Related]
13. Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients.
Darmayanti S; Lesmana R; Meiliana A; Abdulah R
Curr Diabetes Rev; 2021; 17(6):e123120189796. PubMed ID: 33393899
[TBL] [Abstract][Full Text] [Related]
14. Study the Association of Tumor Necrosis Factor Promoter Polymorphism with Type 2 Diabetic Nephropathy.
Emara M; El-Edel R; Fathy WM; Aboelkhair NT; Watany MM; Abou-Elela DH
Mediators Inflamm; 2020; 2020():1498278. PubMed ID: 32684830
[TBL] [Abstract][Full Text] [Related]
15. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.
Tao S; Li L; Li L; Liu Y; Ren Q; Shi M; Liu J; Jiang J; Ma H; Huang Z; Xia Z; Pan J; Wei T; Wang Y; Li P; Lan T; Tang X; Zeng X; Lei S; Tang H; Ma L; Fu P
Acta Diabetol; 2019 May; 56(5):581-592. PubMed ID: 30888537
[TBL] [Abstract][Full Text] [Related]
16. Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.
Jia G; Di F; Wang Q; Shao J; Gao L; Wang L; Li Q; Li N
PLoS One; 2015; 10(11):e0142808. PubMed ID: 26566287
[TBL] [Abstract][Full Text] [Related]
17. Associations between the
Lee DH; Won GW; Lee YH; Ku EJ; Oh TK; Jeon HJ
J Korean Med Sci; 2019 Jun; 34(24):e171. PubMed ID: 31222984
[TBL] [Abstract][Full Text] [Related]
18. ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy.
Sulaj A; Kopf S; Gröne E; Gröne HJ; Hoffmann S; Schleicher E; Häring HU; Schwenger V; Herzig S; Fleming T; Nawroth PP; von Bauer R
J Diabetes Complications; 2017 Jun; 31(6):1058-1065. PubMed ID: 28325697
[TBL] [Abstract][Full Text] [Related]
19. Association of diabetic nephropathy with the severity of obstructive sleep apnea-hypopnea syndrome in patients with type 2 diabetes mellitus.
Dong M; Guo F; Zhou T; Wei Q
Endocr J; 2020 May; 67(5):515-522. PubMed ID: 32023571
[TBL] [Abstract][Full Text] [Related]
20. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F
Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
